Skip to content


Pett Franklin support BioTech with IFRS 2

Pett Franklin are pleased to have supported Ultromics, a world leading BioTech firm which provides autonomous echocardiography analysis through innovative AI solutions.

Cecily Kassinen – Financial Controller at Ultromics
“Pett Franklin provided a helpful and professional service in relation to our share option valuations.  They were integral to our implementation of a third-party software tool to manage share option agreements and were proactive in communicating with external developers to resolve issues on our behalf.  They helped us to navigate use of the tool to support in our Share-Based Payment Calculations and to ensure that it provided reports fit for external audit.  It was a pleasure working with Pett Franklin and we look forward to a continuing relationship with them going forwards”

If you have any questions relating to IFRS 2 or any share scheme, please get in touch via email, or call 0121 281 5798.